Dyne Therapeutics, Inc. - COMMON STOCK, $0.0001 PAR VALUE (DYN)

CUSIP: 26818M108

Q4 2022 13F Holders as of 31 Dec 2022

Holder snapshot 7 signals
Share change
+4,446,598
Put/Call ratio
5.9%
SEC-reported price per share
$11.59
Number of holders
112
Value change
+$50,130,248
Number of buys
55
Open additional details 1 more signal available
Number of sells
41
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
186,643,708

Security key

26818M108

Report period

Q4 2022

Institutions

112

Top holders

10

Ownership snapshot

Top reported holders of DYN - Dyne Therapeutics, Inc. - COMMON STOCK, $0.0001 PAR VALUE (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Atlas Venture Opportunity...
Disclosed value leader
Atlas Venture Life Scienc...
Comparable rows
0/15
Latest evidence
12 Dec 2022
3/4/5 13F Highest disclosed value: $113,473,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Atlas Venture Life Science Advisors, LLC has the largest disclosed position value at $113.47M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Atlas Venture Life Science Advisors, LLC's linked filing trail.
Disclosed position value Top 5
Atlas Venture Opportunity Fund II... $44.51M
Atlas Venture Life Science Adviso... $113.47M
MPM ASSET MANAGEMENT LLC $62.88M
Deep Track Capital, LP $40.44M
CITADEL ADVISORS LLC $37.11M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Atlas Venture Opportunity Fund II, L.P.
3/4/5
10%+ Owner
—
denominator unverified
$44,508,906
2,543,366 shares
— 12 Dec 2022
Atlas Venture Life Science Advisors, LLC
13F
Company
13F
—
denominator unverified
$113,473,000
8,934,902 shares
— 30 Sep 2022
MPM ASSET MANAGEMENT LLC
13F
Company
13F
—
denominator unverified
$62,882,000
4,951,303 shares
— 30 Sep 2022
Deep Track Capital, LP
13F
Company
13F
—
denominator unverified
$40,439,000
3,184,200 shares
— 30 Sep 2022
CITADEL ADVISORS LLC
13F
Company
13F
—
denominator unverified
$37,114,000
2,922,372 shares
— 30 Sep 2022
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$32,069,000
2,525,067 shares
— 30 Sep 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
112
Shares
49,732,095
Rows available
112
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders
100
Q4 2022 holders
112
Holder diff
12
Investor Q3 2022 Shares Q4 2022 Shares Share Diff Share Chg % Q3 2022 value Q4 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .